バリシチニブ (JAK1/2 阻害薬) の臨床試験成績 -アトピー性皮膚炎の新規経口治療薬-
Article in The Nishinihon Journal of Dermatology (August 2021)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Machine learning prediction of inter-fragment interaction energies between ligand and amino-acid residues on the fragment molecular orbital calculations for Janus kinase – inhibitor complex
Article in Chemical Physics Letters (October 2020)
Drug repurposing: Ibrutinib exhibits immunosuppressive potential in organ transplantation
Article in International Journal of Medical Sciences (July 2018)